financetom
Business
financetom
/
Business
/
Rubrik Insider Sold Shares Worth $1,000,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rubrik Insider Sold Shares Worth $1,000,000, According to a Recent SEC Filing
Oct 17, 2024 1:05 PM

05:09 PM EDT, 10/15/2024 (MT Newswires) -- Brian K. McCarthy, Chief Revenue Officer, on October 11, 2024, sold 25,000 shares in Rubrik ( RBRK ) for $1,000,000. Following the Form 4 filing with the SEC, McCarthy has control over a total of 412,545 shares of the company, with 412,545 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1943896/000141588924025123/xslF345X05/form4-10152024_091006.xml

Price: 39.01, Change: -0.12, Percent Change: -0.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien
ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien
Mar 14, 2025
07:22 AM EDT, 03/14/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Friday that the US Food and Drug Administration has now approved Iluvien to treat chronic non-infectious uveitis affecting the eye's posterior segment. The company intends to market the implant for chronic NIU-PS in addition to its current indication of diabetic macular edema in the US. ANI shares...
Eton's Diabetes Drug Candidate Passes Bioequivalence Study
Eton's Diabetes Drug Candidate Passes Bioequivalence Study
Mar 14, 2025
07:20 AM EDT, 03/14/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Friday a bioequivalence study of its product candidate ET-600 showed pharmacokinetic equivalence to the U.S. Food and Drug Administration (FDA)-approved reference product of the same active ingredient. ET-600 is an oral solution of desmopressin under development for the treatment of central diabetes insipidus. Eton said it expects...
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Mar 14, 2025
07:21 AM EDT, 03/14/2025 (MT Newswires) -- On the data docket for Canada at 8:30 a.m. ET Friday are manufacturers' shipments and wholesale trade both for January, said Bank of Montreal (BMO). They are expected to spike around 2% month over month in January, partly in anticipation of United States tariffs, noted the bank. New motor vehicle sales look to...
New Gold Accepts Over $288 Million of 2027 Notes in Tender Offer
New Gold Accepts Over $288 Million of 2027 Notes in Tender Offer
Mar 14, 2025
07:15 AM EDT, 03/14/2025 (MT Newswires) -- New Gold ( NGD ) said Friday that holders submitted roughly $288.8 million worth of its 7.5% notes due 2027 by the March 13 deadline. The company said this amount accounts for just over 72% of the $400 million total, excluding those filed under guaranteed delivery procedures. All valid submissions are expected to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved